Search results for "CEM"

A new replacement name for the fossil spider Veterator Petrunkevitch, 1963 (Arthropoda: Arachnida: Araneae)

2021

A junior homonym was detected in the genera of fossil Araneae and the following replacement name is proposed within the family Trochanteriidae: Neoveterator Ceccolini & Cianferoni nom. nov. pro Veterator Petrunkevitch, 1963 nec Laws, 1944. Eight new combinations (comb. nov.) are proposed.

Comunicare il restauro

2017

Le nuove, estese concezioni del patrimonio culturale collegate alle tecnologie della comunicazione, devono essere l'occasione per una cultura dell'integrazione che faccia lavorare insieme le due componenti, Heritage e Digital- in una visione consapevolmente interdisciplinare, forse anche transdisciplinare, che lavori alla ri-composizione dei saperi e a quella di essi con il contesto fisico-sociale. This paper puts forward a comparison between the traditional way of communicating cultural heritage and a new approach that not only involves the physical use of cultural assets, but also the understanding of their identity and history, through intangible technological systems of communication. T…

Competition Advocacy: Soft Power in Competitive Policy

2013

Abstract Changing market conditions stimulate modernization of criteria, norms and standards of competition regulation and methods of enforcement. Competition advocacy is a type of activity exercised by antimonopoly authorities to strengthen competitive environment without enforcement measures, through developing active cooperation with other government bodies and increasing the degree of understanding of the benefits of competition by the community.

Private Enforcement in Italy

2020

Directive 2014/104/EU on certain rules governing actions for damages under national law for infringements of the competition law provisions of the Member States and of theEuropeanUnion has been transposed in Italy by means of LegislativeDecree no. 3 of 2017, whichlargely reproduces the Directive not only with regard to the structure but also in respect of the wording of the provisions. As with ot her Member States, for example France,Italian lawmakers opted to enact a lex specialis for antitrust damages actions and limited the implementation to what was necessary, without any amendment to the codes of Italy, neither to the Code of Civil Procedure nor to the Civil Code, the latter of which c…

The path to privatization of EU antitrust enforcement: a critical estimate (欧盟反垄断法私人执行的批判)

2012

Influence of Biologically Oriented Preparation Technique on Peri-Implant Tissues; Prospective Randomized Clinical Trial with Three-Year Follow-Up. Pa…

2019

Purpose: The objective of this prospective randomized clinical trial (RCT) was to analyze and compare the clinical behavior of three types of prosthesis supported by single implants in the posterior region after three years of functional loading. Materials and methods: Seventy-five implants were divided into three groups according to the type of prosthetic restoration: screw-retained crown (group GS); cemented crown without finishing line (biologically oriented preparation technique) (group GBOPT); and conventional cemented crown with finishing line (group GCC). After three years in function, clinical parameters (presence of keratinized mucosa, probing depths, bleeding on probing, and radio…

Contratti a valle rimedi civilistici e disciplina della concorrenza

2008

L'entrata in vigore del c.d. regolamento di modernizzazione dell'antitrust europeo (Reg. 1/2003) ha determinato il delinearsi di un sistema misto di enforcement del diritto europeo della concorrenza, ove al tradizionale meccanismo pubblicistico se ne affianca anche uno privatistico. Il volume mette in evidenza le criticità che siffatto impianto di enforcement presenta, tanto dal punto di vista della coerenza complessiva del modello europeo di diritto della concorrenza, quanto dal punto di vista della versatilità dei rimedi del diritto privato ad assolvere ad una qualche funzione di contrasto delle violazioni concorrenziali. Particolare attenzione, entro questa cornice, è dedicata al tema de…

Enzyme replacement and gene therapy for mucopolysaccharidoses: current progress and future directions

2015

Introduction: Mucopolysaccharidoses (MPS) are lysosomal storage disorders caused by the deficiency of enzymes that are responsible for the stepwise degradation of complex carbohydrates, the glycosaminoglycans. Whereas in the past the treatment of MPS consisted mainly of palliative care, enzyme replacement therapy (ERT) is now possible for some MPS disorders, and in the future many other therapeutic options will become available.Areas covered: This review, based on personal experience and the currently available literature, will give an overview on the efficacy and limitations of ERT and will discuss new therapeutic approaches, such as anti-inflammatory drugs, substrate reduction therapy, ch…

Outcome of patients with classical infantile pompe disease receiving enzyme replacement therapy in Germany

2015

Enzyme replacement therapy (ERT) has been shown to improve outcome in classical infantile Pompe disease. The purpose of this study was to assess mortality, morbidity, and shortcomings of ERT in a larger cohort of patients treated outside clinical trials. To accomplish this, we retrospectively analyzed the data of all 23 subjects with classical infantile Pompe disease having started ERT in Germany between January 2003 and December 2010.Ten patients (43%) deceased and four others (17%) became ventilator dependent. Seven infants (30.5%) made no motor progress at all, while seven (30.5%) achieved free sitting, and nine (39%) gained free walking. Besides all the seven patients (100%) attaining n…

Systemic therapies for mucopolysaccharidosis: ocular changes following haematopoietic stem cell transplantation or enzyme replacement therapy - a rev…

2010

The management of mucopolysaccharidosis (MPS) is focused on the multi-organ, sometimes life-threatening, clinical manifestations that occur over time. In the past, the limited, symptom-based treatment options led physicians to adopt a palliative approach towards individual disease-associated complications. The availability of systemic treatments such as haematopoietic stem cell transplantation (HSCT) and enzyme replacement therapy (ERT) has created a better prognosis for MPS patients, particularly when initiated early in life. As part of an integrated management approach, these therapies could be valuable in managing the ocular features that are present in many children with MPS. HSCT has b…